Skip to main content
TipRanks
Go Ultimate75% OFF

Bristol-Myers Squibb (BMY) Stock Statistics & Valuation Metrics

12,194 Followers

Total Valuation

Bristol-Myers Squibb has a market cap or net worth of $129.66B. The enterprise value is $160.34B.

Market Cap
$129.66B
Enterprise Value
$160.34B

Share Statistics

Bristol-Myers Squibb has 2,044,085,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
2,044,085,800
Owned by Insiders
0.03%
Owned by Institutions
67.82%

Financial Efficiency

Bristol-Myers Squibb’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is 15.03%.

Return on Equity (ROE)
0.38
Return on Assets (ROA)
0.08
Return on Invested Capital (ROIC)
15.03%
Return on Capital Employed (ROCE)
0.21
Revenue Per Employee
1.48M
Profits Per Employee
217.05K
Employee Count
32,500
Asset Turnover
0.54
Inventory Turnover
5.18

Valuation Ratios

The current PE Ratio of Bristol-Myers Squibb is 14.03. Bristol-Myers Squibb’s PEG ratio is 0.27.

PE Ratio
14.03
PS Ratio
2.59
PB Ratio
5.54
Price to FCF
13.96
Price to Operating Cash Flow
12.17
PEG Ratio
0.27

Income Statement

In the last 12 months, Bristol-Myers Squibb had revenue of 48.20B and earned 7.05B in profits. Earnings per share was 3.46.

Revenue
48.20B
Gross Profit
34.26B
Operating Income
13.72B
Pretax Income
9.33B
Net Income
7.05B
EBITDA
15.23B
Earnings Per Share (EPS)
3.46

Cash Flow

In the last 12 months, operating cash flow was 10.65B and capital expenditures -1.37B, giving a free cash flow of 9.29B billion.

Operating Cash Flow
10.65B
Free Cash Flow
9.29B
Free Cash Flow per Share
4.55

Dividends & Yields

Bristol-Myers Squibb pays an annual dividend of $0.63, resulting in a dividend yield of 3.97%

Dividend Per Share
$0.63
Dividend Yield
3.97%
Payout Ratio
38.56%
Free Cash Flow Yield
7.16%
Earnings Yield
7.13%

Stock Price Statistics

Beta
0.24
52-Week Price Change
30.43%
50-Day Moving Average
61.65
200-Day Moving Average
59.44
Relative Strength Index (RSI)
56.09
Average Volume (3m)
10.92M

Important Dates

Bristol-Myers Squibb upcoming earnings date is Feb 04, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 29, 2026
Next Earnings Date
Feb 04, 2027
Ex-Dividend Date
Jul 02, 2026

Financial Position

Bristol-Myers Squibb as a current ratio of 1.26, with Debt / Equity ratio of 255.18%

Current Ratio
1.26
Quick Ratio
1.14
Debt to Market Cap
0.41
Net Debt to EBITDA
2.42
Interest Coverage Ratio
7.26

Taxes

In the past 12 months, Bristol-Myers Squibb has paid 2.27B in taxes.

Income Tax
2.27B
Effective Tax Rate
0.24

Enterprise Valuation

Bristol-Myers Squibb EV to EBITDA ratio is 10.88, with an EV/FCF ratio of 17.76.

EV to Sales
3.30
EV to EBITDA
10.88
EV to Free Cash Flow
17.76
EV to Operating Cash Flow
15.48

Balance Sheet

Bristol-Myers Squibb has $12.58B in cash and marketable securities with $44.81B in debt, giving a net cash position of -$32.23B billion.

Cash & Marketable Securities
$12.58B
Total Debt
$44.81B
Net Cash
-$32.23B
Net Cash Per Share
-$15.77
Tangible Book Value Per Share
-$7.47

Margins

Gross margin is 69.24%, with operating margin of 26.07%, and net profit margin of 18.47%.

Gross Margin
69.24%
Operating Margin
26.07%
Pretax Margin
22.65%
Net Profit Margin
18.47%
EBITDA Margin
30.28%
EBIT Margin
25.95%

Analyst Forecast

The average price target for Bristol-Myers Squibb is $65.74, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$65.74
Price Target Upside
3.64% Upside
Analyst Consensus
Moderate Buy
Analyst Count
20
Revenue Growth Forecast
4.19%
EPS Growth Forecast
52.55%

Scores

Smart Score
7
AI Score
69